Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps

摘要: Abstract Data sources A literature search was conducted in Medline (1996 to July 2008) using the terms intensive insulin therapy , pump and continuous subcutaneous infusion . Reference lists from comprehensive review articles were also used identify additional original research publications. Study selection Review studies evaluating role, benefits, risks of CSII. synthesis More than 300,000 individuals use CSII treat diabetes. Many experts believe that is best delivery method for highly motivated patients with type 1 diabetes who are technologically savvy have means pay device sets. useful 2 require multiple daily injections experience wide fluctuations blood glucose throughout day or severe hypoglycemia. variety systems currently available. All provide precise improve accuracy bolus dose calculations, thereby achieving improved glycemic control less frequent hypoglycemic episodes. Patients choose report quality life. Potential associated include mechanical problems leading ketoacidosis, infections at site, hypoglycemia, lipodystrophy. Conclusion an attractive treatment option many Given widespread CSII, all health professionals should be familiar basic features technology, potential benefits how troubleshoot common problems.